June 03, 2019
SOUTH SAN FRANCISCO, Calif, June 3, 2019 – Calico Life Sciences, a company focused on aging research and treatments aimed at age-related diseases, today announced the appointment of Amoolya Singh, Ph.D., as Head of Computing. In this role, Dr. Singh will lead the use of advanced computing capabilities to accelerate Calico’s ability to make new scientific discoveries.
“Calico was founded with the belief that comprehensive computing, data science and machine learning capabilities are key components of bringing new and deep insights to our understanding of aging and age-related diseases, ” said Arthur D. Levinson, Ph.D., CEO and Founder of Calico. “We designed the company to facilitate an interdisciplinary approach to scientific discovery where computational biologists, software engineers and scientists work together to bring world-class technology and know-how to bear on important biological questions. We are beginning to see our approach produce the types of outcomes we initially envisioned. This kind of effort requires a leader with deep expertise in biology and computing, as well as experience leading interdisciplinary teams. It is a very difficult combination of skills to identify in one person and we are excited to have found that person in Amoolya, a highly-accomplished computational biologist and leader. We look forward to her many contributions.”
“I am very excited to be joining Calico and have the opportunity to work side-by-side leading scientists on both basic and translational research toward the development of novel therapeutic interventions,” said Dr. Singh. “Calico scientists are working to answer some truly challenging questions about the biology of aging and disease. I believe the ability to model and learn from our ever-increasing amount of biological data using advanced computational techniques is critical to answering these questions and accelerating scientific discovery.”
Dr. Singh most recently worked at Amyris, a synthetic biology/renewable chemicals company. As Vice President of Research and Development at Amyris, she led a 30-person bioinformatics and software engineering group whose work included innovations in genotype representation and data visualization; building mathematical and statistical models to analyze high-throughput, multivariate genotype and phenotype data; and metabolic modeling and experiments to perturb microbial biochemical pathways and identify bottlenecks.
Dr. Singh earned a Ph.D. in Computational Biology and a master’s degree in Computer Science from the University of California at Berkeley. She received her bachelor’s degree in Biology and Computer Science from Carnegie Mellon. Dr. Singh completed a postdoctoral fellowship at the European Molecular Biology Lab in Heidelberg, Germany and a Computational and Life Sciences fellowship at Emory University in the fields of comparative genomics and metagenomics, population genetics and experimental evolution.
Calico (Calico Life Sciences LLC) is an Alphabet-funded research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. Calico will use that knowledge to devise interventions that enable people to lead longer and healthier lives. To learn more about Calico, visit www.calicolabs.com.